Your browser doesn't support javascript.
loading
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis.
Montalban, Xavier; Gold, Ralf; Thompson, Alan J; Otero-Romero, Susana; Amato, Maria Pia; Chandraratna, Dhia; Clanet, Michel; Comi, Giancarlo; Derfuss, Tobias; Fazekas, Franz; Hartung, Hans Peter; Havrdova, Eva; Hemmer, Bernhard; Kappos, Ludwig; Liblau, Roland; Lubetzki, Catherine; Marcus, Elena; Miller, David H; Olsson, Tomas; Pilling, Steve; Selmaj, Krysztof; Siva, Axel; Sorensen, Per Soelberg; Sormani, Maria Pia; Thalheim, Christoph; Wiendl, Heinz; Zipp, Frauke.
Afiliação
  • Montalban X; Department of Neurology-Neuroimmunology, Multiple Sclerosis Centre of Catalonia (Cemcat), Vall d'Hebron University Hospital, Barcelona, Spain.
  • Gold R; Department of Neurology, Ruhr University, St. Josef-Hospital, Bochum, Germany.
  • Thompson AJ; Department of Brain Repair & Rehabilitation and Faculty of Brain Sciences, University College London Institute of Neurology, London, UK.
  • Otero-Romero S; Department of Neurology-Neuroimmunology, Multiple Sclerosis Centre of Catalonia (Cemcat), Vall d'Hebron University Hospital, Barcelona, Spain/Preventive Medicine and Epidemiology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Amato MP; Department of Neurosciences, Psychology, Drugs and Child Health Area (NEUROFARBA), Section Neurosciences, University of Florence, Florence, Italy.
  • Chandraratna D; Multiple Sclerosis International Federation, London, UK.
  • Clanet M; Department of Neurology, Toulouse University Hospital, Toulouse, France.
  • Comi G; Neurological Department, Institute of Experimental Neurology (INSPE), Scientific Institute Hospital San Raffaele, Universita' Vita-Salute San Raffaele, Milan, Italy.
  • Derfuss T; Departments of Neurology and Biomedicine, University Hospital Basel, Basel, Switzerland.
  • Fazekas F; Department of Neurology, Medical University of Graz, Graz, Austria.
  • Hartung HP; Multiple Sclerosis Center, Department of Neurology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Havrdova E; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic.
  • Hemmer B; Department of Neurology, Klinikum Rechts der Isar, Technische Universität München and Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
  • Kappos L; University Hospital Basel, Basel, Switzerland.
  • Liblau R; INSERM UMR U1043 - CNRS U5282, Université de Toulouse, UPS, Centre de Physiopathologie de Toulouse Purpan, Toulouse, France.
  • Lubetzki C; Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1127, ICM-GHU Pitié-Salpêtrière, Paris, France.
  • Marcus E; Centre for Outcomes Research and Effectiveness (CORE), Research Department of Clinical, Educational and Health Psychology, University College London, London, UK.
  • Miller DH; NMR Research Unit and Queen Square Multiple Sclerosis Centre, University College London Institute of Neurology, London, UK.
  • Olsson T; Neuroimmunology Unit, Center for Molecular Medicine, Karolinska University Hospital Solna, Stockholm, Sweden.
  • Pilling S; Centre for Outcomes Research and Effectiveness (CORE), Research Department of Clinical, Educational and Health Psychology, University College London, London, UK.
  • Selmaj K; Department of Neurology, Medical University of Lodz, Lodz, Poland.
  • Siva A; Clinical Neuroimmunology Unit and MS Clinic, Department of Neurology, Cerrahpasa School of Medicine, Istanbul University, Istanbul, Turkey.
  • Sorensen PS; Department of Neurology, Danish Multiple Sclerosis Center, Copenhagen University Hospital, Rigshospitalet, Denmark.
  • Sormani MP; Biostatistics Unit, University of Genoa, Genoa, Italy.
  • Thalheim C; European Multiple Sclerosis Platform (EMSP), Schaerbeek, Belgium.
  • Wiendl H; Department of Neurology, University of Münster, Münster, Germany.
  • Zipp F; Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunology (FZI), Rhine-Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Mult Scler ; 24(2): 96-120, 2018 02.
Article em En | MEDLINE | ID: mdl-29353550
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Guias de Prática Clínica como Assunto / Medicina Baseada em Evidências / Consenso / Imunomodulação / Fatores Imunológicos / Esclerose Múltipla Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Mult Scler Assunto da revista: NEUROLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Guias de Prática Clínica como Assunto / Medicina Baseada em Evidências / Consenso / Imunomodulação / Fatores Imunológicos / Esclerose Múltipla Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Mult Scler Assunto da revista: NEUROLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha País de publicação: Reino Unido